|
End-of-day quote
Taiwan S.E.
2026-08-28
|
5-day change | 1st Jan Change | ||
| 49.35 TWD | -0.80% |
|
-8.44% | -16.78% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Active Pharmaceutical Ingredients(API) | 3.17B | 3.8B | 4.35B | 4.61B | 4.84B | |||||
Income Tax Expense | 41.61M | 117M | 173M | 113M | 106M | |||||
D&A | 453M | 449M | 467M | 484M | 516M | |||||
Net Income | 1.25B | 409M | 126M | 157M | 441M | |||||
Pharmaceutical Contract Manufacturing Services | ||||||||||
Other Operating Departments | 28.53M | 1.32M | 31.17M | 153M | 16.96M | |||||
Income Tax Expense | 2.4M | -136K | 21.86M | 21.36M | -431K | |||||
D&A | 22.29M | 39.4M | 40.54M | 44.1M | 54.25M | |||||
Net Income | -398M | -403M | -353M | -219M | -86.48M | |||||
Write-Off Due to Consolidation | -55.15M | -39.96M | -17.02M | -27.5M | -7.34M | |||||
Income Tax Expense | - | - | - | -45K | -76K | |||||
D&A | - | -17.89M | -19.66M | -20.81M | -20.71M | |||||
Net Income | 192M | 210M | 175M | 126M | 41.4M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Other | 486M | 614M | 903M | 1.19B | 1.26B | |||||
Total Assets | - | - | - | - | - | |||||
United States | 116M | 190M | 269M | 631M | 870M | |||||
India | 751M | 919M | 1.03B | 1.06B | 755M | |||||
Netherlands | 88.44M | 378M | 577M | 589M | 611M | |||||
China | - | 220M | 273M | 218M | 441M | |||||
Taiwan | 306M | 381M | 278M | 338M | 373M | |||||
Total Assets | 6.24B | 6.24B | 6.35B | 6.45B | 6.88B | |||||
Japan | 254M | 229M | 312M | 263M | 280M | |||||
Total Assets | - | - | - | - | - | |||||
Germany | 247M | 231M | 307M | 251M | 263M | |||||
Spain | 290M | 116M | - | - | - | |||||
Canada | 269M | 209M | 138M | - | - | |||||
Switzerland | 333M | 280M | 272M | 197M | - |
- Stock Market
- Stocks
- 4746 Stock
- Financials Formosa Laboratories, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
